Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (63)	7/5/2002 12:01:49 PM
From: nigel bates	Read Replies (1) \| Respond to of 684

Any chance of attaching either a portfolio, or a watchlist, to the thread ? nig

To: RWReeves who wrote (63)	7/5/2002 12:17:18 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 684

VPHM.... driving me nuts. The more I consider it, the more likely it seems, to me, that the defense against shareholder lawsuits is strong. The drug interactions weren't observed in the trials where treatment duration was short, and the company was walking in with both potential upside and liabilities from the transmission study for picornaviruses. I don't understand how it ever slipped to this level, to begin with. Insights appreciated.

To: RWReeves who wrote (63)	7/5/2002 9:31:12 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 684

This is some data I posted on another biotech thread....pretty sobering to see the carnage taking place in this area of investing...but maybe we have hit bottom: Boy! With the biotechs in the pits, I guess there really isn't much to be said here on the 2002 stock picking thread. Obviously, many of us have shares that have tanked and probably many of these original shares were bought at sub-ten dollars prices. Just to get a better perspective on what has happened this year with biotechs, I had some time today and looked at the Investor's Business Daily list of biotechs on their main NASDAQ listing. This list only contains stocks that were above $10 when they were listed on the list(meaning many of them have dropped below $10 but are still listed in this category) and I identified 75 of these biotechs. And this is what I found for the current prices from their 52 week highs. Stock that have lost what percentage from their respective highs: 0-10% O 10-20% 2 20-30% 3 30-40% 3 40-50% 11 50-60% 19 60-70% 10 70-80% 15 80-90% 9 90-100% 3 As can be seen, the vast majority of these Major Biotechs, they are down more than 50%. For example and looking at those companies that had the highest 52 week share prices, I found: ADRX high of $77.40 now down 73% AMGN high of $69.00 now down 33% CVTX high of $60.90 now down 74% CEPH high of $78.90 now down 49% IMCL high of $75.50 now down 91% GNSS high of $74.90 now down 90% MEDI high of $49.00 now down 53% SEPR high of $60.10 now down 86% VRTX high of $49.40 now down 69% BGEN high of $62.80 now down 41% At least this give me a better perspective on why my original cheap shares are down by the same percentages as some of these previous high flyers and ones with actual earnings